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Early ERCP in Biliary Pancreatitis?
ABSTRACT
Folsch, U. R., Nitsche, R., Ludtke, R., Hilgers, R. A. and
Creutzeldt, W., The Germany Study Group on Acute Biliary
Pancreatitis. (1997) Early ERCP and papillotomy compared
with conservative treatment for acute biliary pancreatits.
New England Journal of Surgery; 336, 237-242.
Background: The role of early endoscopic retrograde
cholangiopancreatography (ERCP) and papillotomy in the
treatment of patients who have acute biliary pancreatitis
without obstructive jaundice is uncertain.
Methods: We conducted a prospective, multicenter study
in which 126 patients were randomly assigned to early
ERCP (within 72 hours after the onset of symptoms) and
endoscopic papillotomy for the removal of stones in the
common bile duct, when appropriate, and 112 patients
were assigned to conservative treatment. In the conserva-
tive-treatment group, ERCP was performed within three
weeks if signs of biliary obstruction or sepsis developed.
Overall mortality, mortality due to pancreatitis, and
complications were compared in the two groups.
Results: Early ERCP was successful in 121 of the 126
patients in the invasive-treatment group. Endoscopic
papillotomy was performed to remove bile-duct stones in
58 patients; stones were successfully extracted in 57. ERCP
was performed in 22 of the 112 patients in the conservative-
treatment group; papillotomy for stone removal was
successful in 13 patients. Fourteen patients in the inva-
sire-treatment group and 7 in the conservative-treatment
group died within three months (P 0.10); 10 patients in
the invasive-treatment group and 4 in the conservative-
treatment group died from acute biliary pancreatitis
(P 0.16). The overall rate of complications was similar
in the two groups, but patients in the invasive-treatment
group had more severe complications. Respiratory failure
was more frequent in the invasive-treatment group, and
jaundice was more frequent in the conservative-treatment
group.
Conclusions: In patients with acute biliary pancreatitis but
without obstructive jaundice, early ERCP and papillotomy
were not beneficial. (N. Engl. J. Med., 1997; 336; 237-42.)
Keywords: Biliary pancreatitis, pancreatitis, ERCP,
sphincterotomy
PAPER DISCUSSION
The report by F61sch and colleagues represents
the fourth published randomised trial of early
ERCP and endoscopic sphincterotomy (ES) ver-
sus conservative management for acute biliary
pancreatitis [1-3]. The premise of the study
design is that patients with coexisting biliary
obstruction have already been shown to benefit
from early endoscopic sphincterotomy. The
study therefore aimed to ascertain benefit for
early sphincterotomy in acute pancreatitis in the
absence of biliary obstruction and concluded that
it was of no benefit. Several flaws in the study,
however, make such a conclusion insupportable.
Antibiotics were not routinely used, although
their use was a feature of at least two of the
previous trials [1, 2], an important difference
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given recent evidence for the positive influence of
antibiotics on outcome in acute pancreatitis [4, 5].
Patients were not prospectively stratified for
predicted severity. This makes any subgroup
analysis statistically meaningless because it is
retrospective. The modified Glasgow severity
criteria were used which can only be determined
48 hours following admission, yet the median
time for intervention was 36 hours. Therefore if
ES was performed sooner than 48 hours a severe
case could have been converted to the mild
category.
Unlike the other randomised trials which
were single centre studies [1,2,3], this study
involved 22 centres meaning that there were
only 2 patients entered per centre per year
(range of total entered 6-29 per centre). This is
difficult to understand as patients were appar-
ently entered consecutively.
No explanation is given as to why 17 patients
in the treatment group developed acute cholan-
gitis (compared to 13 cases in the control group).
Since no other study of ES in acute pancreatitis
approaches such figures we can only presume
that inadequate ES was common.
The high mortality in the treatment group also
runs contrary to any previously published
experience of ES in acute pancreatitis. There
were 12 hospital deaths but only 26 severe cases,
giving a mortality for this group of 46%, or 32%
if all 16 patients with undefined severity are
included. Since deaths from ES in mild acute
pancreatitis are rare, the high mortality raises
serious questions regarding the standard of ES
performed and the overall management of acute
pancreatitis.
In order to detect a mortality difference of 2%
to 8% the authors calculated that 380 patients
were required (190 in each group) for c=0.05
and a power of 80%. The trial however was
stopped after only 238 patients were entered
(63% of the target), so the survival objectives
were not reached. Therefore the study was
seriously underpowered and cannot support
the authors’ own conclusions.
The authors point out that the study from
Hong Kong [3] included some patients with
nonbiliary causes of acute pancreatitis. It is true
that only 65% of the patients had confirmed
gallstones and nearly one third of the conserva-
tive group had ERCP/ES and mostly within 72
hours. Parallel analysis of the Hong Kong and
Leicester studies, however, including only pa-
tients with confirmed gallstones shows remark-
ably similar results including a reduction in local
and systemic complications and death following
intervention (Tab. I).
In the Discussion mention was made of a
randomised study of surgery [6] which reached
the same conclusions as those of the authors.
Indeed that study suffered from similar flaws to
this one including (i) post hoc severity stratifica-
tion and therapeutic intervention before pre-
dicted severity could be determined and (ii) the
TABLE Results of the Leicester [1] and Hong Kong [2] studies of ERCP and ES in acute pancreatitis comparing only those with
proven gallstones comparing mild with severe cases
Numbers of Patients
City Treatment Complications Complications
Mild Local Systemic Deaths Severe Local Systemic Deaths
HONG KONG
ERCP/ES 34 4(12%) 2 (6%) 0 30 3 (10%)
b 3 (10%) (3%)
Conventional 35 (3%) 5(14%)[4] 0 28 8(29%) 16(57%)g[8] 5(18%)k
LEICESTER
ERCP/ES 28 3(11%) 1(4%) 0 22 3 (14%)
d (5%)h 01
Conventional 29 4 (14%) 0 0 24 6 (25%) 9 (38%) 3(13%)
numbers of patients with biliary sepsis. Statistical differences for the mild groups of patients were not significant.
(b+d) vs (c+e): p<0.05, (f+h) vs (g+i): p<0.01, (j+l) vs (k+m): p<0.05.HPB INTERNATIONAL 131
use of a surgical technique which could not
adequately decompress the common channel
(supraduodenal exploration with insertion of a
T-tube).
The weight of evidence from three previous
trials support the use of emergency ES in
patients with severe acute pancreatitis due to
gallstones irrespective of concomitant acute
cholangitis or obstructive jaundice alone. This
requires ES to be performed by properly trained
personnel [7] and can only be of value if there is
a high standard of overall management [1-6].
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Sclerotherapy or Banding for Oesophageal Varices?
ABSTRACT
Sarin, S. K., Govil, A., Jain, A. K., Guptan, R. C., Issar, S.
K., Jain, M. and Murthy, N. S. (1997) Prospective
randomised trial of endoscopic sclerotherapy versus variceal
band ligation for esophageal varices: influence on gastro-
pathy, gastric varices and variceal recurrence. Journal of
Hepatology, 26, 826-832.
Background/Aims: Endoscopic variceal ligation and endo-
scopic sclerotherapy are both recommended for the
prevention of variceal rebleeding. To compare their
prevention of variceal rebleeding. To compare their
efficacy, their influence on gastric varices and the devel-
opment of portal gastropathy, 95 patients with variceal
bleeding were studied.
Methods: The patients were randomized to receive weekly
endoscopic sclerotherapy using alcohol (n=48) or endo-
scopic variceal ligation (n 47). The endoscopic sclerother-
apy and endoscopic variceal ligation groups were
comparable in etiology, severity of liver disease and grade
of varices.
Results: In the arrest of acute bleed, endoscopic sclerother-
apy and endoscopic variceal ligation were comparable (86%
vs. 80%, p ns). Endoscopic variceal ligation as compared to
endoscopic sclerotherapy, obliterated esophageal varices in
fewer sessions (4.1+/-1.2 vs. 5.2+/-1.8, p <0.01) and a shorter
time (4.4+1.3 vs. 6.9+/-3.4 wk, p <0.01). Three (6.4%) patients
bled after endoscopic variceal ligation and 10 (20.8%) after
endoscopic sclerotherapy (p<0.05). The actuarial percentage
of variceal recurrence during a follow-up of 8.5+/-4.4
months, was higher after endoscopic variceal ligation than
endoscopic sclerotherapy (28.7% vs 7.5%, p <0.05). Esopha-
geal stricture formation after endoscopic sclerotherapy
occurred in five (10.4%) patients, but in none after
endoscopic variceal ligation. Significantly more patients
developed gastropathy after endoscopic sclerotherapy than
ligation (20.5% vs. 2.3%; p =0.02). Endoscopic sclerotherapy
(52%) and endoscopic variceal ligation (59%) were equally
effective in obliterating the lesser curve gastric varices. Six
patients died: three in each group.
Conclusion: (i) Endoscopic sclerotherapy and endoscopic
variceal ligation were equally effective in controlling acute
bleed; (ii) endoscopic ligation achieved variceal oblitera-
tion faster and in fewer treatment sessions; (iii) endoscopic
variceal ligation had a significantly lower rate of develop-